NeuroPace (NPCE) Depreciation & Amortization (CF) (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Depreciation & Amortization (CF) of $60000.0 in Q1 2026, down 25.0% quarter-over-quarter from $80000.0 in Q4 2025, and up 22.45% on a YoY basis from $49000.0 in Q1 2025.
NeuroPace (NPCE) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
NeuroPace's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 22.45% year-over-year to $60000.0; the TTM figure through Mar 2026 stood at $340000.0 (up 17.24% YoY), while the FY2025 annual figure was $238000.0, up 19.0% from the prior year.
- Depreciation & Amortization (CF) was $60000.0 for Q1 2026 at NeuroPace, down from $80000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $100000.0 in Q2 2022 to a low of $40000.0 in Q4 2023.
- Historically, Depreciation & Amortization (CF) has averaged $78235.3 across 5 years, with a median of $87000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) sank 54.02% in 2023, then surged 95.12% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $87000.0 in 2022, then tumbled by 54.02% to $40000.0 in 2023, then rose by 2.5% to $41000.0 in 2024, then soared by 95.12% to $80000.0 in 2025, then decreased by 25.0% to $60000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $60000.0 (Q1 2026), $80000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 123.40 Mn |
| 10 | NeuroPace | 526.99 Mn | 473.01 Mn | 18.05 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |